These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1277503)

  • 1. Methotrexate in blood, urine, and cerebrospinal fluid of children receiving high doses by infusion.
    Wang Y; Lantin E; Sutow WW
    Clin Chem; 1976 Jul; 22(7):1053-6. PubMed ID: 1277503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and specific radioimmunoassay for methotrexate.
    Raso V; Schreiber R
    Cancer Res; 1975 Jun; 35(6):1407-10. PubMed ID: 1079473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate in the plasma and cerebrospinal fluid of children treated with intermediate dose methotrexate.
    Rechnitzer C; Scheibel E; Hendel J
    Acta Paediatr Scand; 1981 Sep; 70(5):615-8. PubMed ID: 6976674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate concentration levels in the cerebrospinal fluid during high-dose methotrexate infusions: an unreliable prediction.
    Lippens RJ; Winograd B
    Pediatr Hematol Oncol; 1988; 5(2):115-24. PubMed ID: 3152957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate concentrations in biological fluids: comparison of results obtained by radioimmunoassay and direct ligand binding radioassay.
    Virtanen R; Iisalo E; Parvinen M; Nordman E
    Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):296-302. PubMed ID: 433624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioimmunoassay for methotrexate and its comparison with spectrofluorimetric procedures.
    Loeffler LJ; Blum MR; Nelsen MA
    Cancer Res; 1976 Sep; 36(9 pt.1):3306-11. PubMed ID: 1086132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
    Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
    Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic assay for methotrexate in serum and cerebrospinal fluid.
    Falk LC; Clark DR; Kalman SM; Long TF
    Clin Chem; 1976 Jun; 22(6):785-8. PubMed ID: 819184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic assay of methotrexate, 7-hydroxymethortrexate, 4-deoxy-4-amino-N10-methylpteroic acid and sulfamethoxazole in serum, urine and cerebrospinal fluid.
    Cairnes DA; Evans WE
    J Chromatogr; 1982 Aug; 231(1):103-10. PubMed ID: 7119052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
    Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ
    Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.
    Evans WE; Hutson PR; Stewart CF; Cairnes DA; Bowman WP; Rivera G; Crom WR
    Clin Pharmacol Ther; 1983 Mar; 33(3):301-7. PubMed ID: 6600662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymic inhibition assay for methotrexate with a discrete analyzer, the ABA-100.
    Brown LF; Johnson GF; Witte DL; Feld RD
    Clin Chem; 1980 Feb; 26(2):335-8. PubMed ID: 7353290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid, sensitive and specific radioimmunoassay for methotrexate.
    Paxton JW; Rowell FJ
    Clin Chim Acta; 1977 Nov; 80(3):563-72. PubMed ID: 912922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
    Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A
    Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.
    Buice RG; Evans WE; Karas J; Nicholas CA; Sidhu P; Straughn AB; Meyer MC; Crom WR
    Clin Chem; 1980 Dec; 26(13):1902-4. PubMed ID: 7002366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].
    Janka GE; Wiesner H; Bidlingmaier F; Haas RJ
    Klin Wochenschr; 1979 Apr; 57(8):411-6. PubMed ID: 313478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate levels in the blood and cerebrospinal fluid in children with acute lymphoid leukemia treated with medium doses of methotrexate].
    Borsi J; Koós R; Révész T; Schuler D
    Orv Hetil; 1984 Oct; 125(44):2667-8, 2671-3. PubMed ID: 6387586
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
    Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
    Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.